Holocene Advisors, LP Exact Sciences Corp Transaction History
Holocene Advisors, LP
- $22.6 Billion
- Q2 2024
A detailed history of Holocene Advisors, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Holocene Advisors, LP holds 4,038,634 shares of EXAS stock, worth $266 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
4,038,634
Previous 2,498,373
61.65%
Holding current value
$266 Million
Previous $173 Million
1.1%
% of portfolio
0.75%
Previous 0.66%
Shares
5 transactions
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.2 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.09 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$975 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$796 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$542 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.7B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...